Strategies for Bulk Storage and Shipment of Proteins

Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals

Volumn , Issue , 2010, Pages 677-704

  Jameel, Feroz ^a   Padala, Chakradhar ^a   Randolph, Theodore W ^b  

^a AMGEN INC   (United States)

^b University of Colorado at Boulder   (United States)

Author keywords

Bulk storage and protein shipment strategies; Business and logistic considerations, bulk storage and shipment technology and total cost of manufacturing; Cryogranulation, free flowing, frozen granules alternative means of storage for bulk drug substance

Indexed keywords

EID: 79954419528     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470595886.ch27     Document Type: Chapter

References (45)

1. Akers, M. J. and Schmidt, D. J. (1997), Cryogranulation: A potential new final process for bulk drug substances, BioPharm 10: 28-32.
2. Arford, J. R., Kendric, B. S., Carpenter, J. F., and Randolph, T. W. (2008), High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics, Journal of Pharmaceutical Sciences 97(8): 3005-3021.
3. Hora, M. S. and Chen, B.-L. (1999), Stabilization of biopharmaceutical products and finished product formulation, in Biopharmaceutical, an Industrial Perspective, Walsh, G. and Murphy, B., eds., Kluwer Academic Publishers, pp. 217-248.
4. Banga, A. K. under print, 2010 Therapeutic Peptides and Proteins-Formulation, Processing and Delivery Systems, 2nd ed., Taylor & Francis, London.
5. Chen, B., Bautista, R., Yu, K., Zapata, G. A., Mulkerrin, M. G., and Chamow, S. M. (2003), Effect of histidine on stability and physical properties of an antibody, Pharm. Res. 20(12): 1952-1960.
6. Lam, X. M., Yang, J. Y., and Cleland, J. L. (1997), Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2, J. Pharm Sci. 86: 1250-1255.
7. Waterman, K. C., Adami, R. C., Alsante, K. M., Hong, J., Landis, M. S., Lombardo, F., and Roberts, C. J. (2002), Stabilization of pharmaceuticals to oxidative degradation, Pharm. Devel. Technol. 7(1): 1-32.
8. Lam, P., Keck, R., Lo, S., Wong, R., and Hsu, C. (2003), Effects of formulation components on the corrosion of 316L stainless steel, paper presented at American Chemical Society (ACS) New Orleans Conf. 2003.
9. Lentz, Y. K., Weck, S., and Lam, X. (2007), Evaluation of Polymeric Bioprocess Bags for Frozen Storage and Shipping of Protein Drug Substance, American Association of Pharmaceutical Scientists/National Biotechnology Conference.
10. CDER Guidance Document (1999), Container Closure Systems for Packaging Human Drugs and Biologics.
11. Jaenicke, R., (2000), Stability and stabilization of globular protein in solution, J. Biotechnol. 79: 193-203.
12. Manning, M. C., Patel, K., and Borchardt, R. T. (1989), Stability of protein pharmaceuticals, Pharm. Res. 6: 903-918.
13. Wang, W., Singh, S., Zeng, D. L., King, K., and Nema, S. (2006), Antibody structure, instability and formulation, J. Pharm. Sci. 96(1).
14. Kerwin, B. and Remmele, R. L., Jr. (2007), Protect from light: Photodegradation and protein biologics, J. Pharm. Sci. 96(6): 1468-1479.
15. Mahler, H. C., M̈uller, R., Friess, W., Delille, A., and Matheus, S. (2005), Induction and analysis of aggregates in a liquid IgG1-antibody formulation, Eur. J. Pharm. Biopharm. 59(3): 407-417.
16. Cromwell, M. E. M., Hilario, E., and Jacobson, F. (2006), Protein aggregation and bioprocessing, AAPS J. 8(3): E572-E579.
17. Maa, Y. F., and Hsu, C. C. (1998), Investigation on fouling mechanisms for recombinant human growth hormone sterile filtration, J. Pharm. Sci. 87(7): 808-812.
18. Ahrer, K., Buchacher, A., Iberer, G., and Jungbauer, A. (2006), Effects of ultra-/diafiltration conditions on present aggregates in human immunoglobulin G preparations, J. Membrane Sci. 274(1-2): 5 108-115.
19. Hanson, M. A. and Rouan, S. K. E. (1992), Introduction to formulation of protein pharmaceuticals, in Stability of Protein Pharmaceuticals, Ahern, T. J. and Manning, M. C., eds., Plenum Press, New York, pp. 209-233.
20. Arakawa, T. and Timasheff, S. N. (1985), The stabilization of proteins by osmolytes. Biophys. J. 47: 411-414.
21. Franks, F. (1985), Biophysics and Biochemistry at Low Temperatures, Cambridge Univ. Press, New York.
22. Murase, N. and Franks, F. (1989), Salt precipitation during the freeze-concentration of phosphate buffer solutions, Biophys. Chem. 34: 293-300.
23. van den Berg, L. and Rose, D. (1959), Effect of freezing on the pH and composition of sodium and potassium phosphate solutions: The reciprocal system KH2PO4-Na2HPO4-H2O, Arch. Biochem. Biophys. 81: 319-329.
24. Gomez, G., Pikal, M. J., and Rodriguez-Hornedo, N. (2001), Effect of initial buffer composition on pH changes during far- from-equilibrium freezing of sodium phosphate buffer solutions, Pharm. Res. 18: 90-97.
25. Poulsen, K. P., and Lindelov, F. (1981), Acceleration of chemical reactions due to freezing in Water Activity: Influences on Food Quality, Rockand, L. B. and Stewart, G. F., eds., Academic Press, New York, pp. 651-677.
26. Ahmad, F., and Bigelow, C. (1986), Thermodynamic stability of proteins in salt solutions: A comparison of the effectiveness of protein stabilizers, J. Protein Chem. 5: 355-367.
27. Hyclone Labs., Inc. (1992), Freezing and thawing serum and other biological materials: Optimal procedures minimize damage and maximize shelf-life, in Art to Science in Tissue Culture, Hyclone Labs, inc., Vol. 11, # 2 (spring 1992).
28. Webb, S. D., Golledge, S. L., Cleland, J. L., and Carpenter, J. F. (2002), Surface adsorption of recombinant human interferon-γ in lyophilized and spray-lyophilized formulations, J. Pharm. Sci. 91: 1474-1487.
29. Pikal, M. J. (1999), Mechanisms of protein stabilization during freeze-drying and storage: The relative importance of thermodynamic stabilization and glassy state relaxation dynamics, in Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products, Rey, L. and May, J. eds., Marcel Dekker, New York, Chapter 6.
30. Liesebach, J., Rades, T., and Mang, L. (2003), A new method for the determination of the unfrozen matrix concentration and the maximal freeze-concentration, Thermochim. Acta 401(2): 159-168.
31. Barbaroux, M. and Voute, N., Characterization of Stedim 71 performance at sub-zero temperature, Sartorius-Stedim (unpublished).
32. Wilkins, J., Sesin, D., and Wisniewski, R. (2001), Large-scale cryopreservation of biotherapeutic products, Innov. Pharm. Technol. 1(8): 174-180.
33. Lam, P. and Sane, S. (2007), Design and testing of a prototype large-scale bag freeze-thaw system, BioPharm Int. 20: 6-16.
34. Wisniewski, R. (1996), Large-scale freezing and thawing of biopharmaceutical drug product, Proc. 16th Annual Pharmaceutical Technology Conf., Sept. 16-19, 1996.
35. Incropera, F. P. and Dewitt, D. P. (1990), Introduction to Heat Transfer, Wiley, New York.
36. Carpenter, J. F. and Crowe, J. H. (1988), The mechanism of cryoprotection of proteins by solutes, Cryobiology 25: 244-255.
37. Anderson, M. M., Breccia, J. D., and Hatti-Kaul, R. (2000), Stabilizing effect of chemical additives against oxidation of lactate dehydrogenase, Biotechnol. Appl. Biochem. 32: 145-153.
38. Chang, B. S., Kendrick, B. S., and Carpenter, J. F. (1996), Surface-induced denaturation of proteins during freezing and its inhibition by surfactants, J. Pharm. Sci. 85: 1325-1330.
39. Kerwin, B. A. et al. (1998), Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20 degrees C of a recombinant hemoglobin, J. Pharm. Sci. 87(9): 1062-1068.
40. Franks, F. (2003), Protein destabilization at low temperatures, Adv. Protein. Chem. 46: 105-139.
41. Yin, J., Chu, J.-W., Ricci, M. S., Brems, D. N., Wang, D. I. C., and Trout, B. L. Effects of excipients on the hydrogen peroxide-induced oxidation of methionine residues in granulocyte colony-stimulating factor, Pharm. Res. 22.
42. Hill, J. P. and Buckley, P. D. (1991), The use of pH indicators to identify suitable environments for freezing samples in aqueous and mixed aqueous/nonaqueous solutions, Anal. Biochem. 192(2): 358-361.
43. Shalaev, E., Johnson-Elton, T., Chang, L., and Pikal, M. J. (2002), Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperatures: Implications for freeze drying, Pharm. Res. 19: 195-201.
44. MG Scientiifc Supplying Laboratories, http://www.mgscientific.com/service/plastics.asp.
45. Nail, S. and Akers, M. J., eds. (2002), Fundamentals of Freeze Drying in Development and Manufacture of Protein Pharmaceuticals, Springer, New York.